CBMR publications and media appearances in October 2024

Media & Publications

Every month we release a full list of publications from the Center, as well as media appearances by the Center scientists

Professor Jens Juul Holst (Juul Holst Group)

Associate Professor Thomas Frimurer (CCU)

Arumugam Group
Joos R, et al. Examining the healthy human microbiome concept. Nat Rev Microbiol. 2024 Oct 23. doi:,10.1038/s41579-024-01107-0. Epub ahead of print.

Barrès & Kilpeläinen Groups, Rodent Metabolic Phenotyping Platform
Dall M, et al. Our future, we decide: five ways to reform the scientific publication process. Nat Rev Endocrinol. 2024 Oct 28. doi: 10.1038/s41574-024-01056-x. Epub ahead of print.

Barrès Group & Single-Cell Omics Platform
Carper D, et al. Loss of atrial natriuretic peptide signaling causes insulin resistance, mitochondrial dysfunction, and low endurance capacity. Sci Adv. 2024 Oct 11;10(41):eadl4374. doi: 10.1126/sciadv.adl4374. Epub 2024 Oct 9.

Clemmensen Group
Chen W, et al. Bridging brain insulin resistance to Alzheimer's pathogenesis. Trends Biochem Sci. 2024 Oct 1:S0968-0004(24)00209-3. doi: 10.1016/j.tibs.2024.09.004. Epub ahead of print.

Deshmukh Group
Jessen S, et al. Beta₂-Adrenergic Stimulation Induces Resistance Training-Like Adaptations in Human Skeletal Muscle: Potential Role of KLHL41. Scand J Med Sci Sports. 2024 Oct;34(10):e14736. doi: 10.1111/sms.14736.

Gerhart-Hines Group
Lyu YX, et al. Longevity biotechnology: bridging AI, biomarkers, geroscience and clinical applications for healthy longevity. Aging (Albany NY). 2024 Oct 16;16(20):12955-12976. doi: 10.18632/aging.206135. Epub 2024 Oct 16.

Guasch Group
Martínez-González MA, et al. Recent advances in precision nutrition and cardiometabolic diseases. Rev Esp Cardiol (Engl Ed). 2024 Sep 30:S1885-5857(24)00279-2. English, Spanish. doi: 10.1016/j.rec.2024.09.003. Epub ahead of print.

Hansen Group
Leth-Møller KB, et al. Increasing prevalence of galactose-α-1,3-galactose sensitization in the Danish general adult population. Allergy. 2024 Oct 23. doi: 10.1111/all.16360. Epub ahead of print.

Hansen, Loos & Pers Groups
Madsen AL, et al. Genetic architecture of oral glucose-stimulated insulin release provides biological insights into type 2 diabetes aetiology. Nat Metab. 2024 Oct;6(10):1897-1912. doi: 10.1038/s42255-024-01140-6. Epub 2024 Oct 17.

Hansen, Kilpeläinen & Merino Groups
Ramne S, et al. Distinct genetic signals at the FGF21 locus complicate studies of FGF21's role in diet regulation using human cohort data. Mol Metab. 2024 Oct18;90:102049. doi: 10.1016/j.molmet.2024.102049. Epub ahead of print.

Loos Group
Hawkes G, et al. Whole-genome sequencing in 333,100 individuals reveals rare non-coding single variant and aggregate associations with height. Nat Commun. 2024 Oct 3;15(1):8549. doi: 10.1038/s41467-024-52579-w.

Rocheleau G, et al. Rare variant contribution to the heritability of coronary artery disease. Nat Commun. 2024 Oct 9;15(1):8741. doi: 10.1038/s41467-024-52939-6.

Yeum D, et al. Genetic associations with neural reward responsivity to food cues in children. Front Nutr. 2024 Sep 25;11:1387514. doi: 10.3389/fnut.2024.1387514.

Moritz Group
Sugimoto H, et al. iTraNet: a web- based platform for integrated trans-omics network visualization and analysis. Bioinform Adv. 2024 Sep 30;4(1):vbae141. doi: 10.1093/bioadv/vbae141.

Schwartz Group & Computational Chemistry Unit
Petersen JE, et al. Molecular determinants of neuropeptide-mediated activation mechanisms in tachykinin NK1 and NK2 receptors. J Biol Chem. 2024 Oct 29:107948. doi: 10.1016/j.jbc.2024.107948. Epub ahead of print.

Novo Nordisk Foundation Center for Basic Metabolic Research